A 42-year-old man with hemolytic-uremic syndrome associated with gemcitabine therapy for adenocarcinoma of the liver;42-jahriger patient mit hamolytisch-uramischem syndrom unter gemcitabin-therapie eines adenokarzinoms der leber

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 7, 2000, Pages 593-596

  Eckel, F ^a   Lersch, Chr ^a   Erdmann, J ^a   Schmidt, B ^a   Schulte Frohlinde, E ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute renal failure; Anemia; Gemcitabine; Hemolysis; Hemolytic uremic syndrome; Neoplasm; Thrombocytopenia; Thrombotic micro angiopathy

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; D DIMER; FLUOROURACIL; GEMCITABINE; GLUCOCORTICOID; LACTATE DEHYDROGENASE; UREA; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADENOCARCINOMA; ADULT; ANEMIA; ARTICLE; CASE REPORT; ERYTHROCYTE CONCENTRATE; HEMATURIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEG EDEMA; LIVER CARCINOMA; MALE; PROTEINURIA; THROMBOCYTOPENIA; UREA BLOOD LEVEL; VOMITING; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; FATALITY; LIVER TUMOR; REVIEW;

ADENOCARCINOMA; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DISEASE PROGRESSION; FATAL OUTCOME; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE, ACUTE; LIVER NEOPLASMS; MALE;

EID: 0033847023     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7441     Document Type: Article

References (19)

1. The hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura in adulthood. New aspects in their pathophysiology and therapy
2. Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry
3. Phase II trial of cyclophosphamide, folinic acid, 5-fluorouracil, tamoxifen and gemcitabine in advanced pancreatic cancer
4. Initial experience with healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy
5. Hamolytisch-uramische Syndrome: Bilaterale Nierenrindennekrosen bei akuten erworbenen hamolytischen Anamien
6. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome
7. Hemolytic uremic syndrome and metastatic malignancy
8. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents
9. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review
10. Interactions of platelets and endothelial cells with erythrocytes and leukocytes in thrombotic thrombocytopenic purpura
11. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome
12. Phase II trial of gemcitabine (2,2-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
13. Gemcitabine safety overview
14. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
15. Elevated reticulocyte count - A clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: A case report
16. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients
17. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
18. Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: A prospective, randomized study
19. Hemolytic uremic syndromes in childhood